Nanjing Tianyinshan Hospital
3 clinical trials · Sponsor
◉ Watch Nanjing Tianyinshan Hospital
| Record | Firm | Date |
|---|---|---|
| Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC (NCT07516015) | Nanjing Tianyinshan Hospital | 2026-04-10 |
| Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma (NCT06893887) | Nanjing Tianyinshan Hospital | 2025-05-22 |
| Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients (NCT06685653) | Nanjing Tianyinshan Hospital |
Track Nanjing Tianyinshan Hospital automatically
Every clearance here is in the API, with alerts when new ones post.